Lv51
920 积分 2021-06-01 加入
Current and future immunotherapy for breast cancer
4小时前
待确认
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
2个月前
已完结
A modified toxicity probability interval method for dose-finding trials
6个月前
已完结
The rapid enrollment design for Phase I clinical trials
6个月前
已完结
国外创新药Ⅰ期临床试验剂量探索设计方法及其对我国的启示
6个月前
已完结
Targeting Diverse Wounds and Scars: Recent Innovative Bio‐design of Microneedle Patch for Comprehensive Management
8个月前
已完结
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial
8个月前
已完结
Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance
8个月前
已完结
皖公网安备34019202002308
